Context Depending on the pathologic tumour stage, up to 60% of prostate cancer patients
who undergo radical prostatectomy will develop biochemical relapse and require further …

Abstract The first ESMO Consensus Conference on prostate cancer was held in Zurich,
Switzerland, on 17–19 November 2011, with the participation of a multidisciplinary panel of …

Radiotherapy in combination with androgen deprivation therapy (ADT) is a standard
treatment option for men with localized and locally advanced prostate cancer. However …

Background Salvage radiotherapy (SRT) is clinically established in prostate cancer (PC)
patients with PSA persistence or biochemical relapse (BCR) after prior radical surgery …

What's known on the subject? and What does the study add? Previous studies have shown
that robot‐assisted radical prostatectomy (RARP) can be performed in men with high‐risk …

Purpose Accurate estimation of life expectancy is critical for men considering aggressive vs
nonaggressive treatment of early stage prostate cancer. We created an age adjusted …

Men with prostate cancer with positive margins, extraprostatic extension, positive lymph
nodes, high prostate‐specific antigen, or high Gleason Score are at high risk of recurrence …

Men with high-risk localized prostate cancer (PCa) remain a challenge for clinicians. Until
recently, surgery was not the preferred approach, in part because risk of subclinical …

Purpose: Patients with high risk prostate cancer with pT3 tumor and positive surgical
margins have a high risk of biochemical failure after radical prostatectomy and adjuvant …

PURPOSE: To analyze prognostic factors in patients with high-risk prostate cancer treated
with dose-escalated external-beam radiation therapy (EBRT) and androgen deprivation …